Cerity Partners LLC Horizon Therapeutics Public LTD CO Transaction History

Cerity Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $287,635 - $336,340	-2,906 Reduced 40.93%	4,194 $485,000
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $55,684 - $64,955	578 Added 8.86%	7,100 $730,000
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $133,828 - $141,534	-1,247 Reduced 16.05%	6,522 $711,000
Q4 2022 Feb 15, 2023	BUY	$62.39 - $113.8 $118,915 - $216,902	1,906 Added 32.51%	7,769 $884,000
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $345,447 - $496,420	5,863 New	5,863 $363,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.